Newsroom of

Partners4Access

Follow on Social Network
England

At Partners4Access, we believe patients with rare diseases deserve the right to access the most appropriate treatment. Our vision is ensuring fair access for all key stakeholders. By that, we mean fair access to drugs for rare disease patients, fair value for those that fund treatments, access to the smartest clinical option for the disease expert and a fair return on investment for the orphan drug manufacturer. We work with our biotechnology clients in partnership, to think differently

Partners4Access launch new Webinar Series for Gene Therapy – Are we ready yet?

Launching on the 31stth October 2017, at 17.00 BST P4A invites participants to register now to secure their place for this inaugural webinar.As with most innovative and novel areas, gene-therapy is facing misconceptions guided by hopes, promises, misunderstandings and fear.…

Partners4Access expand their gene therapy access team with the appointment of two new analysts

Partners4Access (P4A) the specialists in orphan drug access, has appointed two new analysts to their European team, in line with their expanding activities in gene therapy.Joanna Fernandes and Max Rex will be joining the specialist access consultancy to support P4A's…

P4A attends the Festival of Genomics in Boston

The Festival celebrates the achievements made within genomics and human health. The 1200 attendees aim to "shape ideas, challenge perceptions and foster collaboration" focusing on the four key topics:-          Personalizing Medicine-          Enabling…

Gene-therapy the topic at the World Orphan Drug Congress

qMany rare disease patients lay their hope in gene-therapy development. However, recent experience with Glybera (uniQure) has shown difficulties faced in the launch and access. During the World Orphan Drug Congress in Washington this month, Partners4Access had the opportunity to…

Partners4Access is pleased to announce the addition of Rosa Pandolfo to the London office

Partners4Access, the global access experts for orphan drugs, is pleased to announce that Rosa Pandolfo joined the company's London Office as Senior Consultant. This addition helps further secure P4A's position as the go-to partner for orphan drug manufacturers.Schmitz, Managing Partner…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login